Skip to main content

Animations

MJFF Publications

5651 - 5675 of 9148 Results
Title
Year
  • Year
  • 2026
  • 2025
  • 2024
  • 2018
  • 2023
  • 2018
  • 2013
  • 2018
  • 2017
  • 2012
  • 2024
  • 2014
  • 2017
  • 2016
  • 2022
  • 2020
  • 2022
  • 2026
  • 2015
  • 2023
  • 2018
  • 2018
  • 2018
  • 2015
  • 2017
  • Summary Details
    OPEN
    Title: Prediction of impulse control disorders in Parkinson’s disease through a longitudinal machine learning study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01248-w
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The Genetic Landscape of Hereditary Spastic Paraplegia in Greece
    Journal Name: Clinical Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cge.70113
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Conjugal Synucleinopathies: A Clinicopathologic Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/mds.29783
    Citation Count: 3
  • Summary Details
    OPEN
    Title: PINK 1 autophosphorylation is required for ubiquitin recognition
    Journal Name: The EMBO Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embr.201744981
    Citation Count: 117
  • Summary Details
    OPEN
    Title: Simultaneous Determination of the Size and Shape of Single α-Synuclein Oligomers in Solution
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.3c01393
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Minimal Clinically Important Difference for UPDRS‐III in Daily Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12632
    Citation Count: 65
  • Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
    2013
    Summary Details
    RESTRICTED
    Title: Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70047-4
    Citation Count: 156
  • Summary Details
    OPEN
    Title: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1813365115
    Citation Count: 92
  • Summary Details
    OPEN
    Title: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7
    Citation Count: 58
  • Activity‐dependent secretion of alpha‐synuclein by enteric neurons
    2012
    Summary Details
    RESTRICTED
    Title: Activity‐dependent secretion of alpha‐synuclein by enteric neurons
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.12131
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    Journal Name: eClinicalMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome
    Journal Name: PROTEOMICS
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pmic.201400171
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006
    Citation Count: 26
  • Summary Details
    RESTRICTED
    Title: Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-016-1549-y
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in Drosophila
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29283
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.005
    Citation Count: 63
  • Endolysosomal cholesterol export: More than just NPC1
    2022
    Summary Details
    OPEN
    Title: Endolysosomal cholesterol export: More than just NPC1
    Journal Name: BioEssays
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/bies.202200111
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70236
    Citation Count: 0
  • Genome‐wide variant by serum urate interaction in Parkinson's disease
    2015
    Summary Details
    RESTRICTED
    Title: Genome‐wide variant by serum urate interaction in Parkinson's disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24504
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13506
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
    Journal Name: EBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2018.01.035
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity
    Journal Name: Archives of Toxicology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00204-018-2222-z
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24375
    Citation Count: 51
  • Summary Details
    OPEN
    Title: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27259
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.